ScripLysogene Licenses Gene Therapy Candidate From Yeda Research Advancing a collaboration inked in July 2020, gene therapy specialist Lysogene SA said on 12 April that it is taking its option to license
ScripThe UK company Beckley Psytech is the latest biotech to raise investor funding to support the evaluation of psychedelic compounds, and in particular the serotonin 5HT2-alpha agonist, psilocybin, as